Abstract:Mitochondrial DNA (mtDNA) is a critical genome contained within the mitochondria of eukaryotic cells, with many copies present in each mitochondrion. Mutations in mtDNA often are inherited and can lead to severe health problems, including various inherited diseases and premature aging. The lack of efficient repair mechanisms and the susceptibility of mtDNA to damage exacerbate the threat to human health. Heteroplasmy, the presence of different mtDNA genotypes within a single cell, increases the complexity of these diseases and requires an effective editing method for correction. Recently, gene-editing techniques, including programmable nucleases such as restriction endonuclease, zinc finger nuclease, transcription activator-like effector nuclease, clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeats-associated 9 and base editors, have provided new tools for editing mtDNA in mammalian cells. Base editors are particularly promising because of their high efficiency and precision in correcting mtDNA mutations. In this review, we discuss the application of these techniques in mitochondrial gene editing and their limitations. We also explore the potential of base editors for mtDNA modification and discuss the opportunities and challenges associated with their application in mitochondrial gene editing. In conclusion, this review highlights the advancements, limitations and opportunities in current mitochondrial gene-editing technologies and approaches. Our insights aim to stimulate the development of new editing strategies that can ultimately alleviate the adverse effects of mitochondrial hereditary diseases.

Mitochondrial genome editing: strategies, challenges, and applications

Research Progress in Mitochondrial Gene Editing Technology.

Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review

Enzymatic tools for mitochondrial genome manipulation

Applications of Gene Editing in Mitochondrial Diseases

Mitochondrial diseases and mtDNA editing

Tools for editing the mammalian mitochondrial genome

New potentials of mitochondrial DNA editing

Therapeutic and tampering approaches for mitochondrial associated diseases

Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing

Direct Evidence of CRISPR-Cas9-mediated Mitochondrial Genome Editing

CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering

Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing

Potential of Mitochondrial Genome Editing for Human Fertility Health

Beyond the membrane: Exploring non-viral methods for mitochondrial gene delivery

Genome editing induces the transfer of mitochondrial DNA into the nuclear genome

Transfer of mitochondrial DNA into the nuclear genome during gene editing

In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue

Strand-selective base editing of human mitochondrial DNA using mitoBEs

Therapeutic potential of engineering the mitochondrial genome.

Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome